Inhibrx Biosciences, Inc.
INBX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $152,596 | $277,924 | $273,865 | $131,301 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $420 | $778 | $257 | $878 |
| Inventory | $0 | $0 | $0 | -$878 |
| Other Curr. Assets | $7,382 | $16,656 | $6,371 | $7,811 |
| Total Curr. Assets | $160,398 | $295,358 | $280,493 | $139,112 |
| Property Plant & Equip (Net) | $13,538 | $9,371 | $7,218 | $9,491 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $6,831 | $3,164 | $3,164 | $1,847 |
| Total NC Assets | $20,369 | $12,535 | $10,382 | $11,338 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $180,767 | $307,893 | $290,875 | $150,450 |
| Liabilities | – | – | – | – |
| Payables | $9,245 | $10,954 | $8,326 | $9,125 |
| Short-Term Debt | $1,595 | $2,063 | $1,860 | $1,674 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $166 | $2,034 |
| Other Curr. Liab. | $29,890 | $43,295 | $17,224 | $9,621 |
| Total Curr. Liab. | $40,730 | $56,312 | $27,576 | $22,454 |
| LT Debt | $6,453 | $208,078 | $205,242 | $70,470 |
| Deferred Rev, NC | $0 | $0 | $0 | $110 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $5,033 |
| Total NC Liab. | $6,453 | $208,078 | $205,242 | $75,613 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $6,453 | $3,173 | $3,173 | $0 |
| Total Liabilities | $47,183 | $264,390 | $232,818 | $98,067 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $150,450 |
| Common Stock | $1 | $5 | $4 | $4 |
| Retained Earnings | -$106,132 | -$613,734 | -$372,373 | -$227,147 |
| AOCI | $0 | $0 | $0 | -$150,450 |
| Other Equity | $239,715 | $657,232 | $430,426 | $279,526 |
| Total Equity | $133,584 | $43,503 | $58,057 | $52,383 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $180,767 | $307,893 | $290,875 | $150,450 |
| Net Debt | -$144,548 | -$67,783 | -$66,763 | -$59,157 |